De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Krishna Institute of Medical Sciences Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Abhinay Bollineni
Algemeen directeur
₹22.0m
Totale compensatie
| Percentage CEO-salaris | 77.3% |
| Dienstverband CEO | 5.3yrs |
| Eigendom CEO | 0.07% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 2.4yrs |
Recente managementupdates
Recent updates
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹22m | ₹17m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹3b |
| Mar 31 2023 | ₹20m | ₹15m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹3b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹12m | ₹12m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹9m | ₹9m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹8m | ₹8m | ₹1b |
| Mar 31 2019 | ₹5m | ₹5m | -₹477m |
Compensatie versus markt: De totale vergoeding ($USD 262.46K ) Abhinay } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 591.73K ).
Compensatie versus inkomsten: De vergoeding van Abhinay is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Abhinay Bollineni (36 yo)
5.3yrs
Tenure
₹22,000,000
Compensatie
Dr. Abhinay Bollineni serves as Chief Executive Officer of Krishna Institute of Medical Sciences Limited since July 3, 2019 and has been its Executive Director since January 18, 2019. He holds a bachelor’s...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | no data | ₹38.67m | 32.25% ₹ 71.0b | |
| CEO & Executive Director | 5.8yrs | ₹22.00m | 0.069% ₹ 151.6m | |
| Director of Operations & Wholetime Director | no data | ₹5.80m | geen gegevens | |
| Independent Director | no data | ₹3.52m | geen gegevens | |
| Additional Non-Executive & Independent Director | 2.4yrs | ₹1.06m | geen gegevens | |
| Independent Director | no data | ₹1.06m | geen gegevens | |
| Additional Non-Executive Non-Independent Director | less than a year | geen gegevens | 0.010% ₹ 22.3m | |
| Independent Director | no data | ₹1.06m | geen gegevens |
2.4yrs
Gemiddelde duur
70yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van KIMS wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.4 jaar), wat duidt op een nieuw bestuur.